<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35114136</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-8595</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The lancet. Diabetes &amp; endocrinology</Title><ISOAbbreviation>Lancet Diabetes Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Sexual dimorphism in COVID-19: potential clinical and public health implications.</ArticleTitle><Pagination><StartPage>221</StartPage><EndPage>230</EndPage><MedlinePgn>221-230</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-8587(21)00346-6</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-8587(21)00346-6</ELocationID><Abstract><AbstractText>Current evidence suggests that severity and mortality of COVID-19 is higher in men than in women, whereas women might be at increased risk of COVID-19 reinfection and development of long COVID. Differences between sexes have been observed in other infectious diseases and in the response to vaccines. Sex-specific expression patterns of proteins mediating virus binding and entry, and divergent reactions of the immune and endocrine system, in particular the hypothalamic-pituitary-adrenal axis, in response to acute stress might explain the higher severity of COVID-19 in men. In this Personal View, we discuss how sex hormones, comorbidities, and the sex chromosome complement influence these mechanisms in the context of COVID-19. Due to its role in the severity and progression of SARS-CoV-2 infections, we argue that sexual dimorphism has potential implications for disease treatment, public health measures, and follow-up of patients predisposed to the development of long COVID. We suggest that sex differences could be considered in future pandemic surveillance and treatment of patients with COVID-19 to help to achieve better disease stratification and improved outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bechmann</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barthel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Medicover Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schedl</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Universit&#xe9; C&#xf4;te d'Azur, INSERM, CNRS, iBV, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herzig</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Joint Heidelberg-IDC Translational Diabetes Program Inner Medicine I, Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga</LastName><ForeName>Zsuzsanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebhard</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayr</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; King's British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hantel</LastName><ForeName>Constanze</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beuschlein</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zurich, Switzerland; Department for Endocrinology, Medizinische Klinik und Poliklinik IV, Ludwig-Maximilians-University, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfrum</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Food, Nutrition and Health, ETH Z&#xfc;rich, Schwerzenbach, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perakakis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poston</LastName><ForeName>Lucilla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Women's Health, Faculty of Life Sciences and Medicine, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andoniadou</LastName><ForeName>Cynthia L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Centre for Craniofacial and Regenerative Biology, Faculty of Dental, Oral, and Craniofacial Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siow</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King's British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine and Sciences, King's College London, London, UK; Vascular Biology and Inflammation Section, School of Cardiovascular Medicine and Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainetdinov</LastName><ForeName>Raul R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Institute of Translational Biomedicine and St Petersburg University Hospital, St Petersburg State University, St Petersburg, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dotan</LastName><ForeName>Arad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoenfeld</LastName><ForeName>Yehuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat Gan, Israel; Ariel University, Ariel, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mingrone</LastName><ForeName>Geltrude</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Fondazione Policlinico Universitario Agostino Gemelli Istituto Di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Department of Internal Medicine, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bornstein</LastName><ForeName>Stefan R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit&#xe4;t Dresden, Dresden, Germany; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK. Electronic address: stefan.bornstein@uniklinikum-dresden.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CH/16/3/32406</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/16/14/32397</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Diabetes Endocrinol</MedlineTA><NlmUniqueID>101618821</NlmUniqueID><ISSNLinking>2213-8587</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054624" MajorTopicYN="Y">Health Status Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007030" MajorTopicYN="N">Hypothalamo-Hypophyseal System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010913" MajorTopicYN="N">Pituitary-Adrenal System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012727" MajorTopicYN="Y">Sex Characteristics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests We declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>20</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35114136</ArticleId><ArticleId IdType="pmc">PMC8803381</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(21)00346-6</ArticleId><ArticleId IdType="pii">S2213-8587(21)00346-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grabek A, Dolfi B, Klein B, Jian-Motamedi F, Chaboissier MC, Schedl A. The adult adrenal cortex undergoes rapid tissue renewal in a sex-specific manner. Cell Stem Cell. 2019;25:290&#x2013;296.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">31104943</ArticleId></ArticleIdList></Reference><Reference><Citation>Manuel RSJ, Liang Y. Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine. Autoimmun Rev. 2021;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8026567</ArticleId><ArticleId IdType="pubmed">33609790</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafella KMM, Denton KM. Sex-specific differences in hypertension and associated cardiovascular disease. Nat Rev Nephrol. 2018;14:185&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">29380817</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwani M, Yassin A, Al-Zoubi RM, et al. Sex-based differences in severity and mortality in COVID-19. Rev Med Virol. 2021;31</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014761</ArticleId><ArticleId IdType="pubmed">33646622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Cao P, Chong MKC, et al. COVID-19 and gender-specific difference: analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020. Infect Control Hosp Epidemiol. 2020;41:750&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113032</ArticleId><ArticleId IdType="pubmed">32146921</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Health 5050  The sex, gender and COVID-19 project. https://globalhealth5050.org/the-sex-gender-and-covid-19-project/dataset/</Citation></Reference><Reference><Citation>Geldsetzer P, Mukama T, Jawad N, Riffe T, Rogers A, Sudharsanan N. Sex differences in the mortality rate for coronavirus disease 2019 compared to other causes of death. medRxiv. 2021 doi: 10.1101/2021.02.23.21252314. published online Feb 26. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.23.21252314</ArticleId><ArticleId IdType="pmc">PMC9219381</ArticleId><ArticleId IdType="pubmed">35737205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty D, Nair SS, Hammouda N, et al. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer. Commun Biol. 2020;3:374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343823</ArticleId><ArticleId IdType="pubmed">32641750</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A. Sex differences for fasting levels of glucose and insulin: expanding our understanding. Nat Rev Endocrinol. 2021;17:131.</Citation><ArticleIdList><ArticleId IdType="pubmed">33504972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagou V, M&#xe4;gi R, Hottenga J-J, et al. Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat Commun. 2021;12:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7785747</ArticleId><ArticleId IdType="pubmed">33402679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tramunt B, Smati S, Coudol S, et al. Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study. Eur J Endocrinol. 2021;185:299&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494335</ArticleId><ArticleId IdType="pubmed">34085949</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurnaghan SJ, Weir A, Bishop J, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021;9:82&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832778</ArticleId><ArticleId IdType="pubmed">33357491</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655818</ArticleId><ArticleId IdType="pubmed">29065927</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuis JD, Sharma A, Roelfsema F. Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin North Am. 2013;42:201&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675779</ArticleId><ArticleId IdType="pubmed">23702398</ArticleId></ArticleIdList></Reference><Reference><Citation>Amur S, Parekh A, Mummaneni P. Sex differences and genomics in autoimmune diseases. J Autoimmun. 2012;38:J254&#x2013;J265.</Citation><ArticleIdList><ArticleId IdType="pubmed">22204900</ArticleId></ArticleIdList></Reference><Reference><Citation>Umiker BR, Andersson S, Fernandez L, et al. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. Eur J Immunol. 2014;44:1503&#x2013;1516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028042</ArticleId><ArticleId IdType="pubmed">24500834</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Driscoll DN, De Santi C, McKiernan PJ, McEneaney V, Molloy EJ, Greene CM. Expression of X-linked Toll-like receptor 4 signaling genes in female vs. male neonates. Pediatr Res. 2017;81:831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">28060792</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, M&#xf6;ller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6325731</ArticleId><ArticleId IdType="pubmed">30621780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergh&#xf6;fer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H. TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006;177:2088&#x2013;2096.</Citation><ArticleIdList><ArticleId IdType="pubmed">16887967</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi MC, Tieri P, Ortona E, Ruggieri A. ACE2 expression and sex disparity in COVID-19. Cell Death Discov. 2020;6:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7248455</ArticleId><ArticleId IdType="pubmed">32499922</ArticleId></ArticleIdList></Reference><Reference><Citation>Migeon BR. X-linked diseases: susceptible females. Genet Med. 2020;22:1156&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332419</ArticleId><ArticleId IdType="pubmed">32284538</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159:229&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110237</ArticleId><ArticleId IdType="pubmed">14742282</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthel A, Mohanraj K, Biener AM, Bornstein SR. Metabolic syndrome and COVID-19: endocrine-immune vascular interactions shape the clinical course. Endocrinology. 2020;161</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717211</ArticleId><ArticleId IdType="pubmed">33202024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Schwarz PEH, Ludwig B, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9:786&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzinga SE, Savelieff MG, O'Brien PD, Mendelson FE, Hayes JM, Feldman EL. Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model. Dis Model Mech. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077554</ArticleId><ArticleId IdType="pubmed">33692086</ArticleId></ArticleIdList></Reference><Reference><Citation>Broussard JL, Perreault L, Macias E, et al. Sex differences in insulin sensitivity are related to muscle tissue acylcarnitine but not subcellular lipid distribution. Obesity (Silver Spring) 2021;29:550&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7927726</ArticleId><ArticleId IdType="pubmed">33624435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng L, Jena PK, Hu Y, Wan YY. Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex. Hepatobiliary Surg Nutr. 2021;10:31&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867716</ArticleId><ArticleId IdType="pubmed">33575288</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens GH, Jocken JWE, Blaak EE. Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol. 2021;17:47&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">33173188</ArticleId></ArticleIdList></Reference><Reference><Citation>Karere GM, Cox LA, Bishop AC, et al. Sex differences in microRNA expression and cardiometabolic risk factors in hispanic adolescents with obesity. J Pediatr. 2021;235:138&#x2013;143.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926296</ArticleId><ArticleId IdType="pubmed">33831442</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: a systematic review. Diabetes Metab Syndr. 2020;14:655&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217103</ArticleId><ArticleId IdType="pubmed">32438328</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen A, Bressem K, Albrecht J, et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism. 2020;110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358176</ArticleId><ArticleId IdType="pubmed">32673651</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;ldi M, Farkas N, Kiss S, et al. Visceral adiposity elevates the risk of critical condition in COVID-19: a systematic review and meta-analysis. Obesity (Silver Spring) 2021;29:521&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753720</ArticleId><ArticleId IdType="pubmed">33263191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa A, Wada T, Nishimura S, et al. Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117686</ArticleId><ArticleId IdType="pubmed">32240221</ArticleId></ArticleIdList></Reference><Reference><Citation>Camporez JP, Lyu K, Goldberg EL, et al. Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. J Physiol. 2019;597:3885&#x2013;3903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6876753</ArticleId><ArticleId IdType="pubmed">31206703</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese M, Griffin C, McKernan K, et al. Sex differences in inflammatory responses to adipose tissue lipolysis in diet-induced obesity. Endocrinology. 2019;160:293&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330175</ArticleId><ArticleId IdType="pubmed">30544158</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Klein SL, Garibaldi BT, et al. Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev. 2021;65</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604159</ArticleId><ArticleId IdType="pubmed">33137510</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe1;rquez EJ, Chung CH, Marches R, et al. Sexual-dimorphism in human immune system aging. Nat Commun. 2020;11:751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005316</ArticleId><ArticleId IdType="pubmed">32029736</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray S, Arrowsmith S. The physiological mechanisms of the sex-based difference in outcomes of COVID19 infection. Front Physiol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900431</ArticleId><ArticleId IdType="pubmed">33633588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology. 2020;161</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438701</ArticleId><ArticleId IdType="pubmed">32730568</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers MJ, Petersen BH. Estradiol induced alterations of the immune system--I. Enhancement of IgM production. Int J Immunopharmacol. 1985;7:207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">3874174</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020;526:135&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbarayan K, Ulagappan K, Wickenhauser C, Bachmann M, Seliger B. Immune interaction map of human SARS-CoV-2 target genes: implications for therapeutic avenues. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007772</ArticleId><ArticleId IdType="pubmed">33796097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto TI, Kurniawan A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord. 2021;20:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8003892</ArticleId><ArticleId IdType="pubmed">33816358</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Knighton P, Zaccardi F, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9:293&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009618</ArticleId><ArticleId IdType="pubmed">33798464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Cai Z, Zhang J. DPP-4 inhibitors may improve the mortality of coronavirus disease 2019: a meta-analysis. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136680</ArticleId><ArticleId IdType="pubmed">34015003</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuhasira R, Ayalon-Dangur I, Zaslavsky N, et al. A randomized clinical trial of linagliptin vs. standard of care in patients hospitalized with diabetes and COVID-19. Front Endocrinol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727772</ArticleId><ArticleId IdType="pubmed">35002970</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta N, Takahashi T, Mori T, et al. Hormonal modulation of prolyl endopeptidase and dipeptidyl peptidase IV activities in the mouse uterus and ovary. Acta Endocrinol (Copenh) 1992;127:262&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">1357903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput MS, Sarkar PD, Nirmal NP. Inhibition of DPP-4 activity and neuronal atrophy with genistein attenuates neurological deficits induced by transient global cerebral ischemia and reperfusion in streptozotocin-induced diabetic mice. Inflammation. 2017;40:623&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">28091829</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence. Ther Adv Endocrinol Metab. 2021;12 2042018821989238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844452</ArticleId><ArticleId IdType="pubmed">33552465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SC, Schneeweiss S, Glynn RJ, Doherty M, Goldfine AB, Solomon DH. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Ann Rheum Dis. 2015;74:1968&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263684</ArticleId><ArticleId IdType="pubmed">24919467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazbeck R, Jaenisch SE, Abbott CA. Dipeptidyl peptidase 4 inhibitors: applications in innate immunity? Biochem Pharmacol. 2021;188</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954778</ArticleId><ArticleId IdType="pubmed">33722535</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Iwasaki A. Sex differences in immune responses. Science. 2021;371:347&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">33479140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou T, Mou H, Zhang L, Ojha A, Choe H, Farzan M. Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2. PLoS Pathog. 2021;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845965</ArticleId><ArticleId IdType="pubmed">33465165</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler BA, Habermann AC, Plosa EJ, et al. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. J Clin Invest. 2021;131</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773394</ArticleId><ArticleId IdType="pubmed">33180746</ArticleId></ArticleIdList></Reference><Reference><Citation>Okwan-Duodu D, Lim E-C, You S, Engman DM. TMPRSS2 activity may mediate sex differences in COVID-19 severity. Signal Transduct Target Ther. 2021;6:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919249</ArticleId><ArticleId IdType="pubmed">33649313</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel RM, Majd H, Richter MN, Ghazizadeh Z, Zekavat SM, Navickas A, et al. Androgen signaling regulates SARS-CoV-2 receptor levels and is associated with severe COVID-19 symptoms in men. Cell Stem Cell. 2020;27:876&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670929</ArticleId><ArticleId IdType="pubmed">33232663</ArticleId></ArticleIdList></Reference><Reference><Citation>Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY) 2020;12:10087&#x2013;10098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7346072</ArticleId><ArticleId IdType="pubmed">32501810</ArticleId></ArticleIdList></Reference><Reference><Citation>Leach DA, Mohr A, Giotis ES, et al. The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells. Nat Commun. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249423</ArticleId><ArticleId IdType="pubmed">34210968</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunst JD, Staerke NB, Pahus MH, et al. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19 &#x2014;a double-blind randomized controlled trial. EClinicalMedicine. 2021;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060682</ArticleId><ArticleId IdType="pubmed">33903855</ArticleId></ArticleIdList></Reference><Reference><Citation>Heck AL, Handa RJ. Sex differences in the hypothalamic-pituitary-adrenal axis' response to stress: an important role for gonadal hormones. Neuropsychopharmacology. 2019;44:45&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6235871</ArticleId><ArticleId IdType="pubmed">30111811</ArticleId></ArticleIdList></Reference><Reference><Citation>Handa RJ, Weiser MJ. Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. Front Neuroendocrinol. 2014;35:197&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5802971</ArticleId><ArticleId IdType="pubmed">24246855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Evert K, Stadtm&#xfc;ller M, et al. COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;guas R, Mahdi A, Shretta R, Horby P, Landray M, White L. Potential health and economic impacts of dexamethasone treatment for patients with COVID-19. Nat Commun. 2021;12:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875992</ArticleId><ArticleId IdType="pubmed">33568665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjbar K, Moghadami M, Mirahmadizadeh A, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021;21:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8035859</ArticleId><ArticleId IdType="pubmed">33838657</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Pozzo E, Giacomelli C, Cavallini C, Martini C. Cytokine secretion responsiveness of lymphomonocytes following cortisol cell exposure: sex differences. PLoS One. 2018;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6062061</ArticleId><ArticleId IdType="pubmed">30048487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghandehari S, Matusov Y, Pepkowitz S, et al. Progesterone in addition to standard of care vs standard of care alone in the treatment of men hospitalized with moderate to severe COVID-19: a randomized, controlled pilot trial. Chest. 2021;160:74&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896492</ArticleId><ArticleId IdType="pubmed">33621601</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli M, Zumerle S, Vettor R, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532) Ann Oncol. 2020;31:1040&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202813</ArticleId><ArticleId IdType="pubmed">32387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Goren A, Wambier CG, Herrera S, et al. Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men. J Eur Acad Dermatol Venereol. 2021;35:e13&#x2013;e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536996</ArticleId><ArticleId IdType="pubmed">32977363</ArticleId></ArticleIdList></Reference><Reference><Citation>Dambha-Miller H, Hinton W, Joy M, Feher M, de Lusignan S. Mortality in COVID-19 amongst women on hormone replacement therapy or combined oral contraception: a cohort study. medRxiv. 2021 doi: 10.1101/2021.02.16.21251853. published online Feb 19. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.16.21251853</ArticleId><ArticleId IdType="pmc">PMC9129218</ArticleId><ArticleId IdType="pubmed">35577349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi RE, Simoncini T. Menopause transition: a golden age to prevent cardiovascular disease. Lancet Diabetes Endocrinol. 2021;9:135&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">33485472</ArticleId></ArticleIdList></Reference><Reference><Citation>Okpechi SC, Fong JT, Gill SS, et al. Global sex disparity of COVID-19: a descriptive review of sex hormones and consideration for the potential therapeutic use of hormone replacement therapy in older adults. Aging Dis. 2021;12:671&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7990361</ArticleId><ArticleId IdType="pubmed">33815890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastrelli G, Di Stasi V, Inglese F, et al. Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients. Andrology. 2021;9:88&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7280645</ArticleId><ArticleId IdType="pubmed">32436355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ, et al. Association of circulating sex hormones with inflammation and disease severity in patients with COVID-19. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8150664</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamad N-V, Wong SK, Hasan WNW, et al. The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male. 2018</Citation><ArticleIdList><ArticleId IdType="pubmed">29925283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y-H, Tseng C-P, Cheng M-L, Ho H-Y, Shih S-R, Chiu DT-Y. Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis. 2008;197:812&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199897</ArticleId><ArticleId IdType="pubmed">18269318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann AD, Cohen Y, Chodick G. Glucose-6-phosphate dehydrogenase deficiency and type 2 diabetes. Diabetes care. 2012;35:e58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402279</ArticleId><ArticleId IdType="pubmed">22826451</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyce J. Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19. Endocr Relat Cancer. 2021;28:R47&#x2013;R53.</Citation><ArticleIdList><ArticleId IdType="pubmed">33263566</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro F, Gjoka M, Di Lorenzo G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27:36&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605748</ArticleId><ArticleId IdType="pubmed">33148440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status&#x2014;United States, January 22&#x2013;June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:769&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316319</ArticleId><ArticleId IdType="pubmed">32584795</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7277610</ArticleId><ArticleId IdType="pubmed">32513659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wastnedge EAN, Reynolds RM, van Boeckel SR, et al. Pregnancy and COVID-19. Physiol Rev. 2021;101:303&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7686875</ArticleId><ArticleId IdType="pubmed">32969772</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrielle Dos Santos L, Filho PGG, Silva AMF, et al. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infect. 2021;82:399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880834</ArticleId><ArticleId IdType="pubmed">33589297</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman MM, Abd-Elrahman NM, Bakheet TM. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol. 2021;93:5942&#x2013;5946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426945</ArticleId><ArticleId IdType="pubmed">34171139</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Pekosz A, Park H-S, et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest. 2020;130:6141&#x2013;6150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598041</ArticleId><ArticleId IdType="pubmed">32764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Galasso V, Pons V, Profeta P, Becher M, Brouard S, Foucault M. Gender differences in COVID-19 attitudes and behavior: panel evidence from eight countries. Proc Natl Acad Sci USA. 2020;117:27285&#x2013;27291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7959517</ArticleId><ArticleId IdType="pubmed">33060298</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisch T, Heiler G, Hurt J, Klimek P, Hanbury A, Thurner S. Behavioral gender differences are reinforced during the COVID-19 crisis. Sci Rep. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478918</ArticleId><ArticleId IdType="pubmed">34584107</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A. What reinfections mean for COVID-19. Lancet Infect Dis. 2021;21:3&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550040</ArticleId><ArticleId IdType="pubmed">33058796</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, Vermeersch P, Vandervoort K, et al. Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain. Clin Infect Dis. 2021;73:354&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499557</ArticleId><ArticleId IdType="pubmed">32887979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam JR, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. 2021 doi: 10.1101/2021.11.11.21266068. published online Dec 2. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.11.21266068</ArticleId><ArticleId IdType="pmc">PMC8995029</ArticleId><ArticleId IdType="pubmed">35289632</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E, Ledford H. How bad is Omicron? What scientists know so far. Nature. 2021;600:197&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">34857948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavanaugh AM, Spicer KB, Thoroughman D, Glick C, Winter K. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination&#x2014;Kentucky, May&#x2013;June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1081&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360277</ArticleId><ArticleId IdType="pubmed">34383732</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10:338&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6467501</ArticleId><ArticleId IdType="pubmed">20417416</ArticleId></ArticleIdList></Reference><Reference><Citation>Muir K-L, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26. COV2. S vaccination. N Engl J Med. 2021;384:1964&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063883</ArticleId><ArticleId IdType="pubmed">33852795</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384:2092&#x2013;2101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Cines DB, Bussel JB. SARS-CoV-2 Vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med. 2021;384:2254&#x2013;2256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063912</ArticleId><ArticleId IdType="pubmed">33861524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay DK, Shimabukuro TT, DeStefano F. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA Cardiol. 2021;6:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">34185047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum HG, Hadler SC, Moulia D, et al. Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson &amp; Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices&#x2014;United States, July 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1094&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360272</ArticleId><ArticleId IdType="pubmed">34383735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacisuleyman E, Hale C, Saito Y, et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med. 2021;384:2212&#x2013;2218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117968</ArticleId><ArticleId IdType="pubmed">33882219</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC COVID-19 Vaccine Breakthrough Case Investigations Team COVID-19 vaccine breakthrough infections reported to CDC&#x2014;United States, January 1&#x2013;April 30, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8158893</ArticleId><ArticleId IdType="pubmed">34043615</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann N Y Acad Sci. 2009;1173:600&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">19758205</ArticleId></ArticleIdList></Reference><Reference><Citation>Appel S, Chapman J, Shoenfeld Y. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity. 2007;40:48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">17364497</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard CE, Suetsch C, Bengs S, et al. Sex-and gender-specific risk factors of post-COVID-19 syndrome: a population-based cohort study in Switzerland. medRxiv. 2021 doi: 10.1101/2021.06.30.21259757. published online July 6. (preprint).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.30.21259757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman KW, Lee JJ, Foster GA, Krysztof D, Stramer SL, Lim JK. Sex differences in cytokine production following West Nile virus infection: Implications for symptom manifestation. Pathog Dis. 2019;77</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6465207</ArticleId><ArticleId IdType="pubmed">30915442</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey JP, Fudenberg HH, Ainsworth SK, Loadholt CB. Autoantibodies in healthy subjects of different age groups. Mech Ageing Dev. 1979;10:399&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">381794</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence. Diabetologia. 2003;46:1354&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">13680123</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamsi R. Rogue antibodies could be driving severe COVID-19. Nature. 2021;590:29&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33469204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Voit-Bak K, Donate T, et al. Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Mol Psychiatry. 2021 doi: 10.1038/s41380-021-01148-4. published online June 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01148-4</ArticleId><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Leynaert B, Sunyer J, Garcia-Esteban R, et al. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort. Thorax. 2012;67:625&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">22334535</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Shambat SM, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>